21 datasets found
  1. COVID-19 deaths reported in the U.S. as of June 14, 2023, by age

    • statista.com
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista, COVID-19 deaths reported in the U.S. as of June 14, 2023, by age [Dataset]. https://www.statista.com/statistics/1191568/reported-deaths-from-covid-by-age-us/
    Explore at:
    Dataset authored and provided by
    Statistahttp://statista.com/
    Time period covered
    Jan 1, 2020 - Jun 14, 2023
    Area covered
    United States
    Description

    Between the beginning of January 2020 and June 14, 2023, of the 1,134,641 deaths caused by COVID-19 in the United States, around 307,169 had occurred among those aged 85 years and older. This statistic shows the number of coronavirus disease 2019 (COVID-19) deaths in the U.S. from January 2020 to June 2023, by age.

  2. Distribution of total COVID-19 deaths in the U.S. as of April 26, 2023, by...

    • statista.com
    Updated Sep 15, 2022
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2022). Distribution of total COVID-19 deaths in the U.S. as of April 26, 2023, by age [Dataset]. https://www.statista.com/statistics/1254488/us-share-of-total-covid-deaths-by-age-group/
    Explore at:
    Dataset updated
    Sep 15, 2022
    Dataset authored and provided by
    Statistahttp://statista.com/
    Area covered
    United States
    Description

    As of April 26, 2023, around 27 percent of total COVID-19 deaths in the United States have been among adults 85 years and older, despite this age group only accounting for two percent of the U.S. population. This statistic depicts the distribution of total COVID-19 deaths in the United States as of April 26, 2023, by age group.

  3. d

    The geographic latitude-associated anti-COVID capacity index : an...

    • dataone.org
    • dataverse.harvard.edu
    Updated Nov 8, 2023
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Errasfa, Mourad (2023). The geographic latitude-associated anti-COVID capacity index : an epidemiologic, demographic, and climate-based parameter negatively correlated with the COVID-19 death tolls [Dataset]. http://doi.org/10.7910/DVN/AXNZUA
    Explore at:
    Dataset updated
    Nov 8, 2023
    Dataset provided by
    Harvard Dataverse
    Authors
    Errasfa, Mourad
    Description

    During the first two year of the Covid-19 pandemic, deaths tolls differed from a country to another. In a previous research work on 39 countries, we have found that some population’s characteristics were either negatively (birth rate/mortality rate, fertility rate) or positively (cancer score, Alzheimer disease score, percent of people above 65 years old, levels of alcohol intake) correlated with Covid-19 mortality. We also found that low levels of climate factors (average annual temperature, average hours of sunshine, average annual level of UV index) were positively correlated with Covid-19 deaths numbers as well. In the present study, we have developped an anti-Covid Capacity index that takes into account all the above mentioned parameters. The polynomial analysis of the anti-Covid Capacity and its corresponding geographic latitude of each country has generated a bell-shaped curve, with a high coefficient of determination (R2= 0.78). Lower anti-Covid capacity values were recorded in countries of low and high latitudes, respectively. Instead, plotting covid-19 deaths numbers against geographic latitude levels has generated an inverted bell-shaped curve, with higher deaths numbers at low and high latitudes, respectively. The analysis by a simple linear regression has shown that Covid-19 deaths numbers were significantly (p= 2,40 x 10-9) and negatively correlated to the anti-Covid Capacity index values. Our data demonstrate that the negative prepandemic human conditions, and the low scores of both annual temperature and UV index in many countries were the key factors behind high Covid-19 mortality, and they can be expressed as a simple index of anti-Covid capacity of a country that can predict the death-associated severity of Covid-19 disease, and thus, according to a country’s geographic latitude.

  4. COVID-19 deaths in the United Kingdom 2020-2022, by age and gender

    • statista.com
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista, COVID-19 deaths in the United Kingdom 2020-2022, by age and gender [Dataset]. https://www.statista.com/statistics/1291744/covid-19-deaths-in-the-united-kingdom-by-age-and-gender/
    Explore at:
    Dataset authored and provided by
    Statistahttp://statista.com/
    Time period covered
    2020 - 2022
    Area covered
    United Kingdom
    Description

    As of February 4, 2022, in the age group 75 to 84 years old COVID-19 was involved in the deaths of 32,780 males and 23,390 females in the United Kingdom. Furthermore, since the pandemic started over 72 thousand deaths in the UK among those aged 85 years and above involved COVID-19. For further information about the COVID-19 pandemic, please visit our dedicated Facts and Figures page.

  5. Number of person-weeks and observed, expected, and excess number of deaths...

    • plos.figshare.com
    xls
    Updated May 31, 2023
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Helen Strongman; Helena Carreira; Bianca L. De Stavola; Krishnan Bhaskaran; David A. Leon (2023). Number of person-weeks and observed, expected, and excess number of deaths during Wave 1 (5 March to 27 May 2020). [Dataset]. http://doi.org/10.1371/journal.pmed.1003870.t001
    Explore at:
    xlsAvailable download formats
    Dataset updated
    May 31, 2023
    Dataset provided by
    PLOShttp://plos.org/
    Authors
    Helen Strongman; Helena Carreira; Bianca L. De Stavola; Krishnan Bhaskaran; David A. Leon
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Description

    Number of person-weeks and observed, expected, and excess number of deaths during Wave 1 (5 March to 27 May 2020).

  6. COVID-19 deaths in England 2020-2022, by age

    • statista.com
    Updated Oct 11, 2023
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2023). COVID-19 deaths in England 2020-2022, by age [Dataset]. https://www.statista.com/statistics/1291746/covid-19-deaths-in-england-by-age/
    Explore at:
    Dataset updated
    Oct 11, 2023
    Dataset authored and provided by
    Statistahttp://statista.com/
    Time period covered
    2020 - 2022
    Area covered
    England
    Description

    As of February 17, 2022, there had been approximately 139.5 thousand deaths due to COVID-19 recorded in England. When broken down by age, almost 37 percent of these deaths occurred in the age group 80 to 89 years, while a further fifth of deaths were recorded among over 90 year olds. For further information about the COVID-19 pandemic, please visit our dedicated Facts and Figures page.

  7. Table_2_Decrease in COVID-19 adverse outcomes in adults during the Delta and...

    • frontiersin.figshare.com
    docx
    Updated Jun 2, 2023
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Lenin Domínguez-Ramírez; Itzel Solis-Tejeda; Jorge Ayon-Aguilar; Antonio Mayoral-Ortiz; Francisca Sosa-Jurado; Rosana Pelayo; Gerardo Santos-López; Paulina Cortes-Hernandez (2023). Table_2_Decrease in COVID-19 adverse outcomes in adults during the Delta and Omicron SARS-CoV-2 waves, after vaccination in Mexico.docx [Dataset]. http://doi.org/10.3389/fpubh.2022.1010256.s003
    Explore at:
    docxAvailable download formats
    Dataset updated
    Jun 2, 2023
    Dataset provided by
    Frontiers Mediahttp://www.frontiersin.org/
    Authors
    Lenin Domínguez-Ramírez; Itzel Solis-Tejeda; Jorge Ayon-Aguilar; Antonio Mayoral-Ortiz; Francisca Sosa-Jurado; Rosana Pelayo; Gerardo Santos-López; Paulina Cortes-Hernandez
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Description

    Mexico, one of the countries severely affected by COVID-19, accumulated more than 5. 1 all-cause excess deaths/1,000 inhabitants and 2.5 COVID-19 confirmed deaths/1,000 inhabitants, in 2 years. In this scenario of high SARS-CoV-2 circulation, we analyzed the effectiveness of the country's vaccination strategy that used 7 different vaccines from around the world, and focused on vaccinating the oldest population first. We analyzed the national dataset published by Mexican health authorities, as a retrospective cohort, separating cases, hospitalizations, deaths and excess deaths by wave and age group. We explored if the vaccination strategy was effective to limit severe COVID-19 during the active outbreaks caused by Delta and Omicron variants. Vaccination of the eldest third of the population reduced COVID-19 hospitalizations, deaths and excess deaths by 46–55% in the third wave driven by Delta SARS-CoV-2. These adverse outcomes dropped 74–85% by the fourth wave driven by Omicron, when all adults had access to vaccines. Vaccine access for the pregnant resulted in 85–90% decrease in COVID-19 fatalities in pregnant individuals and 80% decrease in infants 0 years old by the Omicron wave. In contrast, in the rest of the pediatric population that did not access vaccination before the period analyzed, COVID-19 hospitalizations increased >40% during the Delta and Omicron waves. Our analysis suggests that the vaccination strategy in Mexico has been successful to limit population mortality and decrease severe COVID-19, but children in Mexico still need access to SARS-CoV-2 vaccines to limit severe COVID-19, in particular those 1–4 years old.

  8. f

    Data_Sheet_1_Socioeconomic disparities associated with mortality in patients...

    • datasetcatalog.nlm.nih.gov
    • frontiersin.figshare.com
    Updated Apr 20, 2023
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Galvis, Lina Marcela Ruiz; Rey, Boris Anghelo Rodríguez; Barengo, Noël Christopher; Valencia, Paula Andrea Díaz; Jiménez, Johnatan Cardona; Bedoya, Juan Pablo Pérez; Aguirre, Carlos Andrés Pérez; Cardozo, Oscar Ignacio Mendoza (2023). Data_Sheet_1_Socioeconomic disparities associated with mortality in patients hospitalized for COVID-19 in Colombia.pdf [Dataset]. https://datasetcatalog.nlm.nih.gov/dataset?q=0000947420
    Explore at:
    Dataset updated
    Apr 20, 2023
    Authors
    Galvis, Lina Marcela Ruiz; Rey, Boris Anghelo Rodríguez; Barengo, Noël Christopher; Valencia, Paula Andrea Díaz; Jiménez, Johnatan Cardona; Bedoya, Juan Pablo Pérez; Aguirre, Carlos Andrés Pérez; Cardozo, Oscar Ignacio Mendoza
    Area covered
    Colombia
    Description

    Socioeconomic disparities play an important role in the development of severe clinical outcomes including deaths from COVID-19. However, the current scientific evidence in regard the association between measures of poverty and COVID-19 mortality in hospitalized patients is scant. The objective of this study was to investigate whether there is an association between the Colombian Multidimensional Poverty Index (CMPI) and mortality from COVID-19 in hospitalized patients in Colombia from May 1, 2020 to August 15, 2021. This was an ecological study using individual data on hospitalized patients from the National Institute of Health of Colombia (INS), and municipal level data from the High-Cost Account and the National Administrative Department of Statistics. The main outcome variable was mortality due to COVID-19. The main exposure variable was the CMPI that ranges from 0 to 100% and was categorized into five levels: (i) level I (0%−20%), (ii) level II (20%−40%), (iii) level III (40%−60%), (iv) level IV (60%−80%); and (v) level V (80%−100%). The higher the level, the higher the level of multidimensional poverty. A Bayesian multilevel logistic regression model was applied to estimate Odds Ratio (OR) and their corresponding 95% credible intervals (CI). In addition, a subgroup analysis was performed according to the epidemiological COVID-19 waves using the same model. The odds for dying from COVID-19 was 1.46 (95% CI 1.4–1.53) for level II, 1.41 (95% CI 1.33–1.49) for level III and 1.70 (95% CI 1.54–1.89) for level IV hospitalized COVID-19 patients compared with the least poor patients (CMPI level I). In addition, age and male sex also increased mortality in COVID-19 hospitalized patients. Patients between 26 and 50 years-of-age had 4.17-fold increased odds (95% CI 4.07–4.3) of death compared with younger than 26-years-old patients. The corresponding for 51–75 years-old patients and those above the age of 75 years were 9.17 (95% CI 8.93–9.41) and 17.1 (95% CI 16.63–17.56), respectively. Finally, the odds of death from COVID-19 in hospitalized patients gradually decreased as the pandemic evolved. In conclusion, socioeconomic disparities were a major risk factor for mortality in patients hospitalized for COVID-19 in Colombia.

  9. Number of deaths from COVID-19 in Canada as of May 2, 2023, by age

    • statista.com
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista, Number of deaths from COVID-19 in Canada as of May 2, 2023, by age [Dataset]. https://www.statista.com/statistics/1228632/number-covid-deaths-canada-by-age/
    Explore at:
    Dataset authored and provided by
    Statistahttp://statista.com/
    Area covered
    Canada
    Description

    As of May 2, 2023, of 34,206 COVID-19 cases deceased in Canada, around 4,058 were aged 60 to 69 years. This statistic shows the number of COVID-19 deaths in Canada as of May 2, 2023, by age.

  10. Leading causes of death, total population, by age group

    • www150.statcan.gc.ca
    • ouvert.canada.ca
    • +1more
    Updated Feb 19, 2025
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Government of Canada, Statistics Canada (2025). Leading causes of death, total population, by age group [Dataset]. http://doi.org/10.25318/1310039401-eng
    Explore at:
    Dataset updated
    Feb 19, 2025
    Dataset provided by
    Statistics Canadahttps://statcan.gc.ca/en
    Area covered
    Canada
    Description

    Rank, number of deaths, percentage of deaths, and age-specific mortality rates for the leading causes of death, by age group and sex, 2000 to most recent year.

  11. Distribution of coronavirus deaths in Italy as of May 2023, by age group

    • statista.com
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista, Distribution of coronavirus deaths in Italy as of May 2023, by age group [Dataset]. https://www.statista.com/statistics/1106367/coronavirus-deaths-distribution-by-age-group-italy/
    Explore at:
    Dataset authored and provided by
    Statistahttp://statista.com/
    Time period covered
    May 3, 2023
    Area covered
    Italy
    Description

    The spread of coronavirus (COVID-19) in Italy has not hit uniformly people of every age, as about 60 percent of the individuals infected with the virus were under 50 years old. However, deaths occurred mostly among the elderly. The virus has claimed approximately 190 thousand lives, but, as the chart shows, roughly 85 percent of the victims were older people, aged 70 years or more. People between 80 and 89 years were the most affected, with roughly 76 thousand deaths within this age group.

    Number of total cases Since the first case was detected, coronavirus has spread quickly across Italy. As of April 2023, authorities have reported over 25.8 million cases in the country. This figure includes the deceased, the recovered, and current active cases. COVID recoveries represent the vast majority, reaching approximately 25.5 million.

    Regional differences In terms of COVID cases, Lombardy has been the hardest hit region, followed by the regions of Campania, and Veneto. Likewise, in terms of deaths, Lombardy was the region with the highest number, with roughly 46 thousand losses. On the other hand, this is also the region with the highest number of COVID-19 vaccine administered doses, with a figure of approximately 25.5 million.

    For a global overview visit Statista's webpage exclusively dedicated to coronavirus, its development, and its impact.

  12. Characteristic information of participants.

    • plos.figshare.com
    xls
    Updated Aug 18, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Graciela Trujillo Hernández; David Menendez; Seung Heon Yoo; Rebecca E. Klapper; Maria H. Schapfel; Kailee A. Sowers; Victoria E. Welch; Karl S. Rosengren (2025). Characteristic information of participants. [Dataset]. http://doi.org/10.1371/journal.pone.0330506.t001
    Explore at:
    xlsAvailable download formats
    Dataset updated
    Aug 18, 2025
    Dataset provided by
    PLOShttp://plos.org/
    Authors
    Graciela Trujillo Hernández; David Menendez; Seung Heon Yoo; Rebecca E. Klapper; Maria H. Schapfel; Kailee A. Sowers; Victoria E. Welch; Karl S. Rosengren
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Description

    Information discussed between parents and children provide a foundation for children's developing understanding of health and illness. Parents of 3-to-7-year-old children (N = 516, 62% female, 78% White) residing in the United States were recruited using Amazon’s Mechanical Turk during July 29th– August 10th, 2020. We asked parents to report three questions that their children had asked about the COVID-19 pandemic and asked them to report how they responded to those questions. Children’s questions focused on lifestyle changes (22%), while parental responses were often about the virus (23%). We examined the stability of content of children’s questions and parental responses between the first peak and second peak of infection and death rates due to COVID-19 in the United States. The topic of children’s questions and the types of parental responses shifted between the two peaks, such that parents during the second peak of the pandemic reported their children asking more frequently about the virus and preventive measures than children in the first peak. Meanwhile, parents during the second peak of infection and death rates were more focused on responding to their children’s questions with information about the virus. We used Latent Class Analysis to explore overall patterns in children’s questions and parents’ responses. For children’s questions, three latent classes were obtained: (1) the virus [39%], (2) the virus/lifestyle changes [21%], and (3) lifestyle changes/preventive measures [40%]. For parents’ responses three latent classes were found: (1) the virus/self-protection [54%], (2) reassurance/the virus [28%], and (3) simple yes/no answers without further explanation [17%]. These results suggest that children’s questions and parental responses can be captured in terms of a discrete number of latent classes.

  13. Death rate by age and sex in the U.S. 2021

    • statista.com
    • akomarchitects.com
    Updated Oct 25, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2024). Death rate by age and sex in the U.S. 2021 [Dataset]. https://www.statista.com/statistics/241572/death-rate-by-age-and-sex-in-the-us/
    Explore at:
    Dataset updated
    Oct 25, 2024
    Dataset authored and provided by
    Statistahttp://statista.com/
    Time period covered
    2021
    Area covered
    United States
    Description

    In the United States in 2021, the death rate was highest among those aged 85 and over, with about 17,190.5 men and 14,914.5 women per 100,000 of the population passing away. For all ages, the death rate was at 1,118.2 per 100,000 of the population for males, and 970.8 per 100,000 of the population for women. The death rate Death rates generally are counted as the number of deaths per 1,000 or 100,000 of the population and include both deaths of natural and unnatural causes. The death rate in the United States had pretty much held steady since 1990 until it started to increase over the last decade, with the highest death rates recorded in recent years. While the birth rate in the United States has been decreasing, it is still currently higher than the death rate. Causes of death There are a myriad number of causes of death in the United States, but the most recent data shows the top three leading causes of death to be heart disease, cancers, and accidents. Heart disease was also the leading cause of death worldwide.

  14. Logistic regression model for the association of sociodemographic factors...

    • plos.figshare.com
    xls
    Updated Jun 15, 2023
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Erika Cardoso dos Reis; Phillipe Rodrigues; Tatielle Rocha de Jesus; Elma Lúcia de Freitas Monteiro; Jair Sindra Virtuoso Junior; Lucas Bianchi (2023). Logistic regression model for the association of sociodemographic factors and symptoms with death by COVID-19, Espírito Santo, Brazil, 2020. [Dataset]. http://doi.org/10.1371/journal.pone.0263723.t005
    Explore at:
    xlsAvailable download formats
    Dataset updated
    Jun 15, 2023
    Dataset provided by
    PLOShttp://plos.org/
    Authors
    Erika Cardoso dos Reis; Phillipe Rodrigues; Tatielle Rocha de Jesus; Elma Lúcia de Freitas Monteiro; Jair Sindra Virtuoso Junior; Lucas Bianchi
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Area covered
    Brazil, State of Espírito Santo
    Description

    Logistic regression model for the association of sociodemographic factors and symptoms with death by COVID-19, Espírito Santo, Brazil, 2020.

  15. f

    Women with cancer and COVID-19: an analysis of lethality and clinical...

    • datasetcatalog.nlm.nih.gov
    • scielo.figshare.com
    Updated Mar 24, 2021
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Nogueira, Lídier Roberta Moraes; de Andrade, Lívia Barboza; Orange, Flávia Augusta; Lima, Jurema Telles Oliveira; da Silva Caseca Galindo, Rafaella Joanna; Sena, Gabrielle Ribeiro; de Lima, Tiago Pessoa Ferreira (2021). Women with cancer and COVID-19: an analysis of lethality and clinical aspects in Pernambuco [Dataset]. https://datasetcatalog.nlm.nih.gov/dataset?q=0000891888
    Explore at:
    Dataset updated
    Mar 24, 2021
    Authors
    Nogueira, Lídier Roberta Moraes; de Andrade, Lívia Barboza; Orange, Flávia Augusta; Lima, Jurema Telles Oliveira; da Silva Caseca Galindo, Rafaella Joanna; Sena, Gabrielle Ribeiro; de Lima, Tiago Pessoa Ferreira
    Area covered
    State of Pernambuco
    Description

    Abstract Objectives: to analyze the lethality and clinical characteristics in Pernambuco women with neoplasia that were infected by SARS-CoV-2. Methods: a cross-sectional, retrospective study with female patients with neoplasm sin the state of Pernambuco registered and made available by the Secretariat of Planning and Management of the State of Pernambuco (SEPLAG PE). Secondary data from public domain notifications and the independent factors associated with death were analyzed through logistic regression. The value ofp<0.25 was considered significant in the bivariate analysis and for a multivariate analysis, the value ofp<0.05 was considered significant. Results: forty-nine women died. The mean age and standard deviation were 58.75 ± 20.93 years. 55.86% of the patients were 60 years old or more. The overall lethality rate was 72.06% (CI95%=59.8 - 82.2). The most prevalent symptoms were fever (70.59%), cough (58.82%), dyspnea (57.35%) and O2 saturation less than 95% (48.53%). Conclusions: female patients, with cancer and infected by SARS-CoV-2 are particularly susceptible to death, regardless of the presence of comorbidities or age, with peripheral O2 saturation <95% being the only independent factor associated with death in this group.

  16. n

    Data from: Use of medicinal plants for COVID-19 prevention and respiratory...

    • data.niaid.nih.gov
    • datadryad.org
    zip
    Updated Sep 20, 2021
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Magaly Villena-Tejada; Ingrid Vera-Ferchau; Anahi Cardona-Rivero; Rina Zamalloa-Cornejo; Maritza Quispe-Florez; Zany Frisancho-Triveño; Rosario Abarca-Meléndez; Susan Alvarez-Sucari; Christian Mejia; Jaime Yáñez (2021). Use of medicinal plants for COVID-19 prevention and respiratory symptom treatment during the pandemic in Cusco, Peru: A cross-sectional survey [Dataset]. http://doi.org/10.5061/dryad.ghx3ffbpg
    Explore at:
    zipAvailable download formats
    Dataset updated
    Sep 20, 2021
    Dataset provided by
    Universidad Norbert Wiener
    National University of Saint Anthony the Abbot in Cuzco
    Universidad Continental
    Authors
    Magaly Villena-Tejada; Ingrid Vera-Ferchau; Anahi Cardona-Rivero; Rina Zamalloa-Cornejo; Maritza Quispe-Florez; Zany Frisancho-Triveño; Rosario Abarca-Meléndez; Susan Alvarez-Sucari; Christian Mejia; Jaime Yáñez
    License

    https://spdx.org/licenses/CC0-1.0.htmlhttps://spdx.org/licenses/CC0-1.0.html

    Area covered
    Cusco, Peru
    Description

    Background: The burden of the COVID-19 pandemic in Peru has led to people seeking alternative treatments as preventives and treatment options such as medicinal plants. This study aimed to assess factors associated with the use of medicinal plants as preventive or treatment of respiratory symptom related to COVID-19 during the pandemic in Cusco, Peru.

    Method: A web-based cross-sectional study was conducted on general public (20- to 70-year-old) from August 31 to September 20, 2020. Data were collected using a structured questionnaire via Google Forms, it consisted of an 11-item questionnaire that was developed and validated by expert judgment using Aiken's V (Aiken's V > 0.9). Both descriptive statistics and bivariate followed by multivariable logistic regression analyses were conducted to assess factors associated with the use of medicinal plants for COVID-19 prevention and respiratory symptom treatment during the pandemic. Prevalence ratios (PR) with 95% Confidence Interval (CI), and a P-value of 0.05 was used to determine statistical significance.

    Results: A total of 1,747 respondents participated in the study, 80.2% reported that they used medicinal plants as preventives, while 71% reported that they used them to treat respiratory symptoms. At least, 24% of respondents used medicinal plants when presenting with two or more respiratory symptoms, while at least 11% used plants for malaise. For treatment or prevention, the multivariate analysis showed that most respondents used eucalyptus (p ​​< 0.001 for both), ginger (p​​ < 0.022 for both), spiked pepper (p < 0.003 for both), garlic (p = 0.023 for prevention), and chamomile (p = 0.011 for treatment). The respondents with COVID-19 (p < 0.001), at older ages (p = 0.046), and with a family member or friend who had COVID-19 (p < 0.001) used more plants for prevention. However, the respondents with technical or higher education used less plants for treatment (p < 0.001).

    Conclusion: There was a significant use of medicinal plants for both prevention and treatment, which was associated with several population characteristics and whether respondents had COVID-19.

    Methods We conducted an online cross-sectional multicenter survey, which was initially evaluated by 10 expert judges using Aiken's V (40). After including the experts’ observations, a pilot study was performed (from August 16 to 4) with 336 respondents in in five districts of Cusco, Peru. The pilot data was used to calculate the minimal sample size necessary for the actual study. It was determined that a minimum sample size of 1,530 was necessary to achieve a minimum percentage difference of 2.5% (49.0% versus 51.5%), a statistical power of 80%, and a confidence level of 95%. The sample size was calculated using power analysis.

    The actual survey consisted of an online questionnaire that was sent via WhatsApp, Messenger, and Facebook. The shared questionnaire was made anonymous ensuring data confidentiality and reliability. The survey was performed from August 31 to September 20, 2020 after approximately 9 months of lockdown and social distancing measures in Peru due to the COVID-19 outbreak. At the beginning of the survey (August 31) the number of COVID-19 confirmed cases was 652,037 and 28,944 deaths, while at the end of the survey (September 20) the confirmed cases increased to 772,896 and the deaths increased to 31,474. We surveyed general public who were adults of both genders aged 20 to 70 years in five districts of Cusco, Peru with high-risk COVID-19 transmission according to the Epidemiological Alert AE-017-2020. The five districts were Cusco, San Jerónimo, San Sebastián, Santiago, and Wanchaq. Participants were recruited by the research team of the Universidad Nacional de San Antonio Abad del Cusco.

  17. f

    Latent Classes of Parental Responses.

    • figshare.com
    xls
    Updated Aug 18, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Graciela Trujillo Hernández; David Menendez; Seung Heon Yoo; Rebecca E. Klapper; Maria H. Schapfel; Kailee A. Sowers; Victoria E. Welch; Karl S. Rosengren (2025). Latent Classes of Parental Responses. [Dataset]. http://doi.org/10.1371/journal.pone.0330506.t007
    Explore at:
    xlsAvailable download formats
    Dataset updated
    Aug 18, 2025
    Dataset provided by
    PLOS ONE
    Authors
    Graciela Trujillo Hernández; David Menendez; Seung Heon Yoo; Rebecca E. Klapper; Maria H. Schapfel; Kailee A. Sowers; Victoria E. Welch; Karl S. Rosengren
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Description

    Information discussed between parents and children provide a foundation for children's developing understanding of health and illness. Parents of 3-to-7-year-old children (N = 516, 62% female, 78% White) residing in the United States were recruited using Amazon’s Mechanical Turk during July 29th– August 10th, 2020. We asked parents to report three questions that their children had asked about the COVID-19 pandemic and asked them to report how they responded to those questions. Children’s questions focused on lifestyle changes (22%), while parental responses were often about the virus (23%). We examined the stability of content of children’s questions and parental responses between the first peak and second peak of infection and death rates due to COVID-19 in the United States. The topic of children’s questions and the types of parental responses shifted between the two peaks, such that parents during the second peak of the pandemic reported their children asking more frequently about the virus and preventive measures than children in the first peak. Meanwhile, parents during the second peak of infection and death rates were more focused on responding to their children’s questions with information about the virus. We used Latent Class Analysis to explore overall patterns in children’s questions and parents’ responses. For children’s questions, three latent classes were obtained: (1) the virus [39%], (2) the virus/lifestyle changes [21%], and (3) lifestyle changes/preventive measures [40%]. For parents’ responses three latent classes were found: (1) the virus/self-protection [54%], (2) reassurance/the virus [28%], and (3) simple yes/no answers without further explanation [17%]. These results suggest that children’s questions and parental responses can be captured in terms of a discrete number of latent classes.

  18. f

    Table_1_Effectiveness and Waning of Protection With Different SARS-CoV-2...

    • datasetcatalog.nlm.nih.gov
    • figshare.com
    Updated Jul 22, 2022
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Surján, György; Kenessey, István; Bogos, Krisztina; Vokó, Zoltán; Müller, Veronika; Molnár, Gergő Attila; Rokszin, György; Pálosi, Mihály; Kiss, Zoltán; Wéber, András; Surján, Orsolya; Szekanecz, Zoltán; Wittmann, István; Szlávik, János; Nagy, Péter; Müller, Cecília; Polivka, Lőrinc; Nagy, Dávid; Kásler, Miklós; Barcza, Zsófia (2022). Table_1_Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study).docx [Dataset]. https://datasetcatalog.nlm.nih.gov/dataset?q=0000308557
    Explore at:
    Dataset updated
    Jul 22, 2022
    Authors
    Surján, György; Kenessey, István; Bogos, Krisztina; Vokó, Zoltán; Müller, Veronika; Molnár, Gergő Attila; Rokszin, György; Pálosi, Mihály; Kiss, Zoltán; Wéber, András; Surján, Orsolya; Szekanecz, Zoltán; Wittmann, István; Szlávik, János; Nagy, Péter; Müller, Cecília; Polivka, Lőrinc; Nagy, Dávid; Kásler, Miklós; Barcza, Zsófia
    Area covered
    Hungary
    Description

    BackgroundIn late 2021, the pandemic wave was dominated by the Delta SARS-CoV-2 variant in Hungary. Booster vaccines were offered for the vulnerable population starting from August 2021.MethodsThe nationwide HUN-VE 3 study examined the effectiveness and durability of primary immunization and single booster vaccinations in the prevention of SARS-CoV-2 infection, Covid-19 related hospitalization and mortality during the Delta wave, compared to an unvaccinated control population without prior SARS-CoV-2 infection.ResultsThe study population included 8,087,988 individuals who were 18–100 years old at the beginning of the pandemic. During the Delta wave, after adjusting for age, sex, calendar day, and chronic diseases, vaccine effectiveness (VE) of primary vaccination against registered SARS-CoV-2 infection was between 11% to 77% and 18% to 79% 14–120 days after primary immunization in the 16–64 and 65–100 years age cohort respectively, while it decreased to close to zero in the younger age group and around 40% or somewhat less in the elderly after 6 months for almost all vaccine types. In the population aged 65–100 years, we found high, 88.1%–92.5% adjusted effectiveness against Covid-19 infection after the Pfizer-BioNTech, and 92.2%–95.6% after the Moderna booster dose, while Sinopharm and Janssen booster doses provided 26.5%–75.3% and 72.9%–100.0% adjusted VE, respectively. Adjusted VE against Covid-19 related hospitalization was high within 14–120 days for Pfizer-BioNTech: 76.6%, Moderna: 83.8%, Sputnik-V: 78.3%, AstraZeneca: 73.8%, while modest for Sinopharm: 45.7% and Janssen: 26.4%. The waning of protection against Covid-19 related hospitalization was modest and booster vaccination with mRNA vaccines or the Janssen vaccine increased adjusted VE up to almost 100%, while the Sinopharm booster dose proved to be less effective. VE against Covid-19 related death after primary immunization was high or moderate: for Pfizer-BioNTech: 81.5%, Moderna: 93.2%, Sputnik-V: 100.0%, AstraZeneca: 84.8%, Sinopharm: 58.6%, Janssen: 53.3%). VE against this outcome also showed a moderate decline over time, while booster vaccine types restored effectiveness up to almost 100%, except for the Sinopharm booster.ConclusionsThe HUN-VE 3 study demonstrated waning VE with all vaccine types for all examined outcomes during the Delta wave and confirmed the outstanding benefit of booster vaccination with the mRNA or Janssen vaccines, and this is the first study to provide clear and comparable effectiveness results for six different vaccine types after primary immunization against severe during the Delta pandemic wave.

  19. Leading causes of death among teenagers aged 15-19 years in the United...

    • statista.com
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista, Leading causes of death among teenagers aged 15-19 years in the United States 2020-23 [Dataset]. https://www.statista.com/statistics/1017959/distribution-of-the-10-leading-causes-of-death-among-teenagers/
    Explore at:
    Dataset authored and provided by
    Statistahttp://statista.com/
    Area covered
    United States
    Description

    As of 2023, the third leading cause of death among teenagers aged 15 to 19 years in the United States was intentional self-harm or suicide, contributing to around 17 percent of deaths among this age group. The leading cause of death at that time was unintentional injuries, contributing to around 38.6 percent of deaths, while 20.7 percent of all deaths in this age group were due to assault or homicide. Cancer and heart disease, the overall leading causes of death in the United States, are also among the leading causes of death among U.S. teenagers. Adolescent suicide in the United States In 2021, around 22 percent of students in grades 9 to 12 reported that they had seriously considered attempting suicide in the past year. Female students were around twice as likely to report seriously considering suicide compared to male students. In 2023, New Mexico had the highest rate of suicides among U.S. teenagers, with around 28 deaths per 100,000 teenagers, followed by Idaho with a rate of 22.5 per 100,000. The states with the lowest death rates among adolescents are New Jersey and New York. Mental health treatment Suicidal thoughts are a clear symptom of mental health issues. Mental health issues are not rare among children and adolescents, and treatment for such issues has become increasingly accepted and accessible. In 2021, around 15 percent of boys and girls aged 5 to 17 years had received some form of mental health treatment in the past year. At that time, around 35 percent of youths aged 12 to 17 years in the United States who were receiving specialty mental health services were doing so because they had thought about killing themselves or had already tried to kill themselves.

  20. Annual life expectancy in the United States 1850-2100

    • statista.com
    Updated Nov 19, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2025). Annual life expectancy in the United States 1850-2100 [Dataset]. https://www.statista.com/statistics/1040079/life-expectancy-united-states-all-time/
    Explore at:
    Dataset updated
    Nov 19, 2025
    Dataset authored and provided by
    Statistahttp://statista.com/
    Area covered
    United States
    Description

    From the mid-19th century until today, life expectancy at birth in the United States has roughly doubled, from 39.4 years in 1850 to 79.6 years in 2025. It is estimated that life expectancy in the U.S. began its upward trajectory in the 1880s, largely driven by the decline in infant and child mortality through factors such as vaccination programs, antibiotics, and other healthcare advancements. Improved food security and access to clean water, as well as general increases in living standards (such as better housing, education, and increased safety) also contributed to a rise in life expectancy across all age brackets. There were notable dips in life expectancy; with an eight year drop during the American Civil War in the 1860s, a seven year drop during the Spanish Flu empidemic in 1918, and a 2.5 year drop during the Covid-19 pandemic. There were also notable plateaus (and minor decreases) not due to major historical events, such as that of the 2010s, which has been attributed to a combination of factors such as unhealthy lifestyles, poor access to healthcare, poverty, and increased suicide rates, among others. However, despite the rate of progress slowing since the 1950s, most decades do see a general increase in the long term, and current UN projections predict that life expectancy at birth in the U.S. will increase by another nine years before the end of the century.

Share
FacebookFacebook
TwitterTwitter
Email
Click to copy link
Link copied
Close
Cite
Statista, COVID-19 deaths reported in the U.S. as of June 14, 2023, by age [Dataset]. https://www.statista.com/statistics/1191568/reported-deaths-from-covid-by-age-us/
Organization logo

COVID-19 deaths reported in the U.S. as of June 14, 2023, by age

Explore at:
44 scholarly articles cite this dataset (View in Google Scholar)
Dataset authored and provided by
Statistahttp://statista.com/
Time period covered
Jan 1, 2020 - Jun 14, 2023
Area covered
United States
Description

Between the beginning of January 2020 and June 14, 2023, of the 1,134,641 deaths caused by COVID-19 in the United States, around 307,169 had occurred among those aged 85 years and older. This statistic shows the number of coronavirus disease 2019 (COVID-19) deaths in the U.S. from January 2020 to June 2023, by age.

Search
Clear search
Close search
Google apps
Main menu